Literature DB >> 29611496

Case Report: Role of Interventional Radiology in the Management of Patients with Alveolar Echinococcus: Successful Management of Three Cases.

Merve Gulbiz Dagoglu-Kartal1, Turkmen Ciftci2, Cigdem Ozer3, Devrim Akinci2, Okan Akhan2.   

Abstract

Alveolar echinococcus (AE) is an infestation by Echinococcus multilocularis. Partial hepatectomy or liver transplantation is the first choice of treatment. However, the disease is usually diagnosed at an unresectable stage. In those cases, invasion of the bile ducts and vessels, and necrosis in the center of the lesion lead to severe complications, such as cholangitis and liver abscesses. Palliative surgery has been reported to not offer advantages in management, and percutaneous and endoscopic interventions have become more prominent in management. In this case series, outcomes in three cases with unresectable AE were reported. In one of the cases, interventional procedures were used to manage the complications after surgery. In the second case, the cystic component was aspirated to decrease the size before the surgery and in the third case, it was used to drain biliary tree and no surgery was done.

Entities:  

Mesh:

Year:  2018        PMID: 29611496      PMCID: PMC5953349          DOI: 10.4269/ajtmh.17-0089

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  30 in total

1.  Percutaneous transhepatic biliary drainage: experience with 311 procedures.

Authors:  R W Günther; H Schild; M Thelen
Journal:  Cardiovasc Intervent Radiol       Date:  1988-04       Impact factor: 2.740

2.  Evaluation of treatment and long-term follow-up in patients with hepatic alveolar echinococcosis.

Authors:  Z Kadry; E C Renner; L M Bachmann; N Attigah; E L Renner; R W Ammann; P-A Clavien
Journal:  Br J Surg       Date:  2005-09       Impact factor: 6.939

Review 3.  Cestodes. Echinococcus.

Authors:  R W Ammann; J Eckert
Journal:  Gastroenterol Clin North Am       Date:  1996-09       Impact factor: 3.806

Review 4.  Imaging aspects and non-surgical interventional treatment in human alveolar echinococcosis.

Authors:  Solange Bresson-Hadni; Eric Delabrousse; Oleg Blagosklonov; Brigitte Bartholomot; Stéphane Koch; Jean-Philippe Miguet; Georges André Mantion; Dominique Angèle Vuitton
Journal:  Parasitol Int       Date:  2006-01-05       Impact factor: 2.230

5.  Complete resolution of an alveolar echinococcosis liver lesion following percutaneous treatment.

Authors:  Mert Koroglu; Okan Akhan; Mustafa Tekinalp Gelen; Banu Kale Koroglu; Harun Yildiz; Gonul Kerman; Orhan Oyar
Journal:  Cardiovasc Intervent Radiol       Date:  2006 May-Jun       Impact factor: 2.740

6.  Parasiticidal effect of chemotherapy in alveolar hydatid disease: review of experience with mebendazole and albendazole in Alaskan Eskimos.

Authors:  J F Wilson; R L Rausch; B J McMahon; P M Schantz
Journal:  Clin Infect Dis       Date:  1992-08       Impact factor: 9.079

7.  Alveolar hydatid disease. A review of clinical features of 33 indigenous cases of Echinococcus multilocularis infection in Alaskan Eskimos.

Authors:  J F Wilson; R L Rausch
Journal:  Am J Trop Med Hyg       Date:  1980-11       Impact factor: 2.345

8.  Laparoscopic versus open surgery for hydatid disease of the liver. A single center experience.

Authors:  Ozgur Bostanci; Kinyas Kartal; Pinar Yazici; Onder Karabay; Muharrem Battal; Mehmet Mihmanli
Journal:  Ann Ital Chir       Date:  2016       Impact factor: 0.766

9.  [Treatment of cholestasis caused by stenosis of the intrahepatic bile ducts in alveolar echinococcosis. Trial of biliary drainage by the percutaneous transhepatic approach].

Authors:  P M Bret; P Paliard; C Partensky; M Bretagnolle; P Blanchut
Journal:  Gastroenterol Clin Biol       Date:  1984-04

10.  Late biliary complications in human alveolar echinococcosis are associated with high mortality.

Authors:  Pascal Frei; Benjamin Misselwitz; Meher K Prakash; Alain M Schoepfer; Bettina M Prinz Vavricka; Beat Müllhaupt; Michael Fried; Kuno Lehmann; Rudolf W Ammann; Stephan R Vavricka
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.